105 related articles for article (PubMed ID: 22777152)
1. Plasma concentrations of quetiapine, N-desalkylquetiapine, o-desalkylquetiapine, 7-hydroxyquetiapine, and quetiapine sulfoxide in relation to quetiapine dose, formulation, and other factors.
Fisher DS; Handley SA; Flanagan RJ; Taylor DM
Ther Drug Monit; 2012 Aug; 34(4):415-21. PubMed ID: 22777152
[TBL] [Abstract][Full Text] [Related]
2. Measurement of quetiapine and four quetiapine metabolites in human plasma by LC-MS/MS.
Fisher DS; Handley SA; Taylor D; Flanagan RJ
Biomed Chromatogr; 2012 Sep; 26(9):1125-32. PubMed ID: 22241669
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic variability of quetiapine and the active metabolite N-desalkylquetiapine in psychiatric patients.
Bakken GV; Rudberg I; Molden E; Refsum H; Hermann M
Ther Drug Monit; 2011 Apr; 33(2):222-6. PubMed ID: 21383647
[TBL] [Abstract][Full Text] [Related]
4. Impact of genetic variability in CYP2D6, CYP3A5, and ABCB1 on serum concentrations of quetiapine and N-desalkylquetiapine in psychiatric patients.
Bakken GV; Molden E; Hermann M
Ther Drug Monit; 2015 Apr; 37(2):256-61. PubMed ID: 25254417
[TBL] [Abstract][Full Text] [Related]
5. Distribution of quetiapine and metabolites in biological fluids and tissues.
Vignali C; Freni F; Magnani C; Moretti M; Siodambro C; Groppi A; Osculati AMM; Morini L
Forensic Sci Int; 2020 Feb; 307():110108. PubMed ID: 31877542
[TBL] [Abstract][Full Text] [Related]
6. Effect of N-Desalkylquetiapine/Quetiapine Plasma Level Ratio on Anxiety and Depression in Bipolar Disorder: A Prospective Observational Study.
Rovera C; Mauri MC; Di Pace C; Paletta S; Reggiori A; Ciappolino V; Cattaneo D; Baldelli S; Clementi E; Altamura AC
Ther Drug Monit; 2017 Aug; 39(4):441-445. PubMed ID: 28486308
[TBL] [Abstract][Full Text] [Related]
7. Steady-state pharmacokinetic, safety, and tolerability profiles of quetiapine, norquetiapine, and other quetiapine metabolites in pediatric and adult patients with psychotic disorders.
Winter HR; Earley WR; Hamer-Maansson JE; Davis PC; Smith MA
J Child Adolesc Psychopharmacol; 2008 Feb; 18(1):81-98. PubMed ID: 18294091
[TBL] [Abstract][Full Text] [Related]
8. N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity.
Jensen NH; Rodriguiz RM; Caron MG; Wetsel WC; Rothman RB; Roth BL
Neuropsychopharmacology; 2008 Sep; 33(10):2303-12. PubMed ID: 18059438
[TBL] [Abstract][Full Text] [Related]
9. Self-reported sedation profile of quetiapine extended-release and quetiapine immediate-release during 6-day initial dose escalation in bipolar depression: a multicenter, randomized, double-blind, phase IV study.
Riesenberg RA; Baldytcheva I; Datto C
Clin Ther; 2012 Nov; 34(11):2202-11. PubMed ID: 23059166
[TBL] [Abstract][Full Text] [Related]
10. Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics.
Grimm SW; Richtand NM; Winter HR; Stams KR; Reele SB
Br J Clin Pharmacol; 2006 Jan; 61(1):58-69. PubMed ID: 16390352
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of quetiapine by CYP3A4 and CYP3A5 in presence or absence of cytochrome B5.
Bakken GV; Rudberg I; Christensen H; Molden E; Refsum H; Hermann M
Drug Metab Dispos; 2009 Feb; 37(2):254-8. PubMed ID: 19022943
[TBL] [Abstract][Full Text] [Related]
12. Quetiapine Carboxylic Acid and Quetiapine Sulfoxide Prevalence in Patient Urine.
Strickland EC; Cummings OT; Morris AA; Clinkscales A; McIntire GL
J Anal Toxicol; 2016 Oct; 40(8):687-693. PubMed ID: 27562964
[TBL] [Abstract][Full Text] [Related]
13. Impact of age, sex and cytochrome P450 genotype on quetiapine and N-desalkylquetiapine serum concentrations: A study based on real-world data from 8118 patients.
Solhaug V; Tveito M; Waade RB; Høiseth G; Molden E; Smith RL
Br J Clin Pharmacol; 2023 Dec; 89(12):3503-3511. PubMed ID: 37438870
[TBL] [Abstract][Full Text] [Related]
14. Relationship between daily dose, plasma concentrations, dopamine receptor occupancy, and clinical response to quetiapine: a review.
Sparshatt A; Taylor D; Patel MX; Kapur S
J Clin Psychiatry; 2011 Aug; 72(8):1108-23. PubMed ID: 21294996
[TBL] [Abstract][Full Text] [Related]
15. Plasma quetiapine in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 2000-2011.
Handley SA; Bowskill SV; Patel MX; Flanagan RJ
Ther Adv Psychopharmacol; 2013 Jun; 3(3):129-37. PubMed ID: 24167685
[TBL] [Abstract][Full Text] [Related]
16. Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: a randomized, double-blind, crossover study in healthy adult subjects.
Datto C; Berggren L; Patel JB; Eriksson H
Clin Ther; 2009 Mar; 31(3):492-502. PubMed ID: 19393840
[TBL] [Abstract][Full Text] [Related]
17. Single-dose relative bioavailability of a new quetiapine fumarate extended-release formulation: a postprandial, randomized, open-label, two-period crossover study in healthy Uruguayan volunteers.
Estevez-Carrizo FE; Parrillo S; Ercoli MC; Estevez-Parrillo FT
Clin Ther; 2011 Jun; 33(6):738-45. PubMed ID: 21704238
[TBL] [Abstract][Full Text] [Related]
18. Influence of age, gender, body weight and valproate comedication on quetiapine plasma concentrations.
Aichhorn W; Marksteiner J; Walch T; Zernig G; Saria A; Kemmler G
Int Clin Psychopharmacol; 2006 Mar; 21(2):81-5. PubMed ID: 16421458
[TBL] [Abstract][Full Text] [Related]
19. The Distribution of Quetiapine and 7-Hydroxyquetiapine in Guinea Pig Hair Roots and Shafts after Repeated Administration: Exploration of the Mechanism of Drug Entry and Retention in Hair.
Ji JJ; Yan H; Xiang P; Wang X; Shen M
J Anal Toxicol; 2021 Nov; 45(9):1042-1051. PubMed ID: 33242096
[TBL] [Abstract][Full Text] [Related]
20. Quetiapine and drug interactions: evidence from a routine therapeutic drug monitoring service.
Castberg I; Skogvoll E; Spigset O
J Clin Psychiatry; 2007 Oct; 68(10):1540-5. PubMed ID: 17960969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
